← Leaderboards
Reben Raeman
Emory University
$4,012,130
Attributed
$5,230,157
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,230,157 · 3
By mechanism
R01$4,528,543 · 2
K01$701,614 · 1
Top collaborators
- Michael Oertel4 shared
Most similar at Emory University
Same institution · by research overlap
- Nitika Arora Gupta$753,680
- Michael Duane Powell$199,702
- John David Altman$15,306,298
- Aftab A. Ansari$22,344,206
- Jason W Upton$1,620,147
Others in their field
Other Emerging Leaders on “Cirrhosis”
- Amit Singal · Ut Southwestern Medical Center$15,105,435
- Marina Serper · University Of Pennsylvania$7,301,871
- Cynthia A Moylan · Duke University$5,972,949
- Valerian Nakaar · Carogen Corporation$4,718,929
- Jody D. Ciolino · Northwestern University At Chicago$4,372,157
- Yazhen Zhu · University Of California Los Angeles$4,089,586
Research focus
CirrhosisLiverMediatingPathogenesisHepaticDisease ProgressionInflammationLiver TransplantationMetabolicMouse ModelPublishingPlayCellsCytokineImmuneClinically RelevantNon-Alcoholic Fatty Liver DiseaseFeedingAttenuatedImpairmentIncidenceFibrosisImmunoregulationInflammatory
Grant awards (14)
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease$423,551
R01 · FY2025 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$595,568
R01 · FY2024 · DK
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease$406,609
R01 · FY2024 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$616,187
R01 · FY2023 · DK
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease$423,551
R01 · FY2023 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$616,187
R01 · FY2022 · DK
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease$421,886
R01 · FY2022 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$608,113
R01 · FY2021 · DK
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease$416,891
R01 · FY2021 · DK · contact PI
Role of CD4 T cells in the pathogenesis of non-alcoholic steatohepatitis$148,986
K01 · FY2021 · DK · contact PI
Role of CD4 T cells in the pathogenesis of non-alcoholic steatohepatitis$148,986
K01 · FY2020 · DK · contact PI
Role of CD4 T cells in the pathogenesis of non-alcoholic steatohepatitis$148,986
K01 · FY2019 · DK · contact PI
Role of CD4 T cells in the pathogenesis of non-alcoholic steatohepatitis$148,986
K01 · FY2018 · DK · contact PI
Role of CD4 T cells in the pathogenesis of non-alcoholic steatohepatitis$105,670
K01 · FY2017 · DK · contact PI